Taking your company public through an IPO is a crucial step, presenting a unique opportunity to benefit both your business and its investors. Explore the Nasdaq IPO Academy, a program tailored to ...
Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...
BioPharma Ltd. (Quantum BioPharma) announced that its licensee, Celly Nutrition Corporation, is seeking to raise up to $10 million USD and explore an initial public offering on a major U.S ...
After an improving IPO market in 2024, the IPO market may fare well in 2025, especially with some hot names on deck. That ...
Australia's securities regulator has urged the nation's stock exchange operator to be more proactive in making it easier and ...
Beezaasan Explotech IPO allotment will be finalised today, February 27. Investors can check their allotment status via Kfin ...
The heads of three early-stage companies shared lessons from going public in a challenging market for biotech stocks.
Nasdaq’s financial strength has historically been strong, but the acquisition of Adenza in November of 2023 added significant leverage to the firm. That said, the firm is making quick progress in ...
The central bank will do this by partnering with fund managers which manage funds focused on local stocks. Read more at ...
The Sensex closed marginally higher on Tuesday, while the Nifty ended flat, as gains in heavyweight financial and auto stocks ...
Q4 2024 Earnings Call Transcript February 21, 2025 Operator: Good afternoon, everyone, and welcome to AXT’s Fourth Quarter ...
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results